
Oxramet-S 5mg/1000mg/50mg Tablet IR
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Dapagliflozin (5mg) + Metformin (1000mg) + Sitagliptin (50mg)
Overview Oxramet-S 5mg/1000mg/50mg Tablet IR
Diabexe Trio 5mg/1000mg/50mg Immediate-Release tablets are a combined medication for managing blood glucose. This treatment, used alongside diet and exercise, improves glycemic control in adults with type 2 diabetes. It enhances insulin effectiveness, thus reducing blood sugar. Diabexe Trio can be administered with or without food, but consistent daily timing is recommended. Dosage is determined by your physician; discontinuation requires their approval, as cessation may elevate blood sugar, risking severe complications like nephropathy and vision impairment. This medication forms part of a comprehensive treatment plan encompassing healthy eating, regular physical activity, and weight management as directed by your doctor. Frequent side effects include upper respiratory infections, nasal congestion, sore throat, and urinary tract infections. Adequate hydration is crucial to prevent dehydration. Genital fungal infections may occur; diligent hygiene mitigates this risk. Prior to commencing Diabexe Trio, inform your doctor of any kidney or liver disease, urinary tract infections, or diuretic use. Pregnant or lactating individuals must consult their physician before use. Limit alcohol consumption during treatment to minimize potential adverse effects. Regular blood glucose monitoring is essential while using this medication.
Uses of Oxramet-S 5mg/1000mg/50mg Tablet IR
Managing type 2 diabetes
Major Benefits of Oxramet-S 5mg/1000mg/50mg Tablet IR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing. Oxramet-S 5mg/1000mg/50mg Immediate-Release Tablets can be consumed with or without food, however, consistent timing is recommended.
Common Side effects of Oxramet-S 5mg/1000mg/50mg Tablet IR:
- Diarrhea
- Nausea
- Vomiting
- Flatulence
- Polyuria
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Headache
- Hypoglycemia (low blood glucose level)
- Conjunctivitis
- Cough
How to use Oxramet-S 5mg/1000mg/50mg Tablet IR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Oxramet-S 5mg/1000mg/50mg Tablet IR whole; do not alter its form by chewing, crushing, or breaking. While consumption with or without food is acceptable, consistent timing is recommended for optimal results.
How Oxramet-S 5mg/1000mg/50mg Tablet IR works:
Oxramet-S 5mg/1000mg/50mg immediate-release tablets contain a triple-action antidiabetic formula. Dapagliflozin elevates urinary glucose disposal, consequently lowering blood glucose. Metformin reduces both dietary glucose absorption and hepatic glucose production. Furthermore, it enhances insulin sensitivity, improving the body's natural glucose regulation. Sitagliptin regulates blood sugar by boosting incretin levels, stimulating pancreatic insulin secretion and suppressing excessive hepatic glucose output.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of Oxramet-S 5mg/1000mg/50mg Tablet IR with alcohol is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Oxramet-S 5mg/1000mg/50mg immediate-release tablets in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Oxramet-S 5mg/1000mg/50mg immediate-release tablets with breastfeeding are currently lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Oxramet-S 5mg/1000mg/50mg Tablet IR on driving ability is undetermined. Refrain from driving if you encounter symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Oxramet-S 5mg/1000mg/50mg Tablet IR in individuals with renal impairment. Seek medical advice from your physician.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Oxramet-S 5mg/1000mg/50mg Tablet IR use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Oxramet-S 5mg/1000mg/50mg Tablet IR :
NA
Facts to Know About Oxramet-S 5mg/1000mg/50mg Tablet IR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
